Immunological response as a source to variability in drug metabolism and transport
Through the last decades it has become increasingly evident that disease-states involving cytokines affect the pharmacokinetics of drugs through regulation of expression and activity of drug-metabolizing enzymes, and more recently also drug transporters. The clinical implication is however difficult...
Main Authors: | Hege eChristensen, Monica eHermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00008/full |
Similar Items
-
Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation
by: Ahmet Muderrisoglu, et al.
Published: (2020-11-01) -
Hyperlipidemia: Insights into Mechanisms Involved in Modulation of Drug Pharmacokinetics and Response
by: Marwa E. Elsherbiny
Published: (2020-03-01) -
Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01) -
In Vitro Inhibitory Effects of Scutellarin on Six Human/Rat Cytochrome P450 Enzymes and P-glycoprotein
by: Yong-Long Han, et al.
Published: (2014-05-01) -
Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers
by: Dal-Sik Kim, et al.
Published: (2016-10-01)